<html>
<head>PUBMED IDs for IP6K2</head>
<body bgcolor='#C5F0F2'><h1>IP6K2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11337497/'>Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells.</a> May 5  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11896621/'>Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics.</a> March 16  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/14736227/'>Two Trichomonas vaginalis loci encoding for distinct cysteine proteinases show a genomic linkage with putative inositol hexakisphosphate kinase (IP6K2) or an ABC transporter gene.</a> January 23  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/21078964/'>p53-mediated apoptosis requires inositol hexakisphosphate kinase-2.</a> February 1  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21262846/'>Casein kinase-2 mediates cell survival through phosphorylation and degradation of inositol hexakisphosphate kinase-2.</a> March 31  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22446964/'>Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles.</a> July 3  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24956979/'>IP6K structure and the molecular determinants of catalytic specificity in an inositol phosphate kinase family.</a> November 17  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/27140681/'>Deletion of inositol hexakisphosphate kinase 1 (IP6K1) reduces cell migration and invasion, conferring protection from aerodigestive tract carcinoma in mice.</a> February 23  2016<br></body></html>
